On the basis of these data, we suggest that the combined treatment of RuPOP with TRAIL could be a novel strategy to inhibit growth and metastatic potential of tumor cells and synergistically enhance TRAIL-induced apoptotic cell death. Here, TNFSF10 is linked to neoplasm.